First step toward a new ARDS treatment: safety check in healthy volunteers
Knowledge-focused
Not yet recruiting
This study is the first step in testing a new drug called HT31-1 for a serious lung condition called ARDS. In this part, 24 healthy adults will receive a single dose to check if it is safe and how the body processes it. The results will help decide the right dose for future studi…
Phase: PHASE1 • Sponsor: HTIC, Inc • Aim: Knowledge-focused
Last updated May 07, 2026 18:38 UTC